APSS was created to help patients and doctors alike navigate the complexities of acquiring AMPYRA® (dalfampridine) as recommended by their doctors.
One of the most frequent treatments for Multiple Sclerosis is the various nervous system agents’ medication Dalfampridine.
Ampyra is another brand name of Dalfampridine.
Costing
Dalfampridine extended-release oral tablet 10 mg costs between $137 and $138 for a batch of 60 pills, depending on the drugstore you go to. Only cash-paying consumers are eligible for these prices, which are not included in insurance policies.
Also read biktarvy copay assistance
Copay assistance program
A patient assistance program (PAPs) is a program sponsored by a pharmaceutical company that provides free or subsidized medications to low-income individuals who satisfy certain eligibility criteria. Each program has its own set of conditions for participation.
The APSS can verify whether your insurer will cover your AMPYRA prescription and if you are qualified for our co-pay program if you are prescribed the drug. You may be eligible for AMPYRA co-pay help if you have proper commercial insurance (either employer-sponsored or individual) that covers it.
MS-related walking issues might be tough to accept at first. Talking about them with the doctor might be just as difficult.
In order to aid with the conversation, we’ve created this handy doctor’s discussion guide.
Qualified or not
A prescription for AMPYRA may be confirmed by AMPYRA Patient Support Services to see whether you are qualified for our co-pay program and if your insurance will cover the cost of your medication.
If you decide to give AMPYRA a go, the experts will be here to help you every step of the way.
There is a support group for persons with multiple sclerosis and their caregivers who are taking AMPYRA. AMPYRA’s free educational and motivational program is meant to keep you informed, educated, and inspired throughout your AMPYRA journey.
You may also engage in a survey meant to assist you better communicate with your doctor about changes in the walking patterns.
